1. Home
  2. IOTR vs PASG Comparison

IOTR vs PASG Comparison

Compare IOTR & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOTR
  • PASG
  • Stock Information
  • Founded
  • IOTR 2019
  • PASG 2017
  • Country
  • IOTR Singapore
  • PASG United States
  • Employees
  • IOTR N/A
  • PASG N/A
  • Industry
  • IOTR
  • PASG Biotechnology: Pharmaceutical Preparations
  • Sector
  • IOTR
  • PASG Health Care
  • Exchange
  • IOTR NYSE
  • PASG Nasdaq
  • Market Cap
  • IOTR 29.5M
  • PASG 31.1M
  • IPO Year
  • IOTR 2025
  • PASG 2020
  • Fundamental
  • Price
  • IOTR $0.92
  • PASG $0.34
  • Analyst Decision
  • IOTR
  • PASG Strong Buy
  • Analyst Count
  • IOTR 0
  • PASG 3
  • Target Price
  • IOTR N/A
  • PASG $7.67
  • AVG Volume (30 Days)
  • IOTR 2.1M
  • PASG 192.0K
  • Earning Date
  • IOTR 01-01-0001
  • PASG 05-13-2025
  • Dividend Yield
  • IOTR N/A
  • PASG N/A
  • EPS Growth
  • IOTR N/A
  • PASG N/A
  • EPS
  • IOTR N/A
  • PASG N/A
  • Revenue
  • IOTR $9,578,336.00
  • PASG N/A
  • Revenue This Year
  • IOTR N/A
  • PASG N/A
  • Revenue Next Year
  • IOTR N/A
  • PASG N/A
  • P/E Ratio
  • IOTR N/A
  • PASG N/A
  • Revenue Growth
  • IOTR 13.93
  • PASG N/A
  • 52 Week Low
  • IOTR $0.80
  • PASG $0.30
  • 52 Week High
  • IOTR $5.98
  • PASG $1.64
  • Technical
  • Relative Strength Index (RSI)
  • IOTR N/A
  • PASG 41.07
  • Support Level
  • IOTR N/A
  • PASG $0.31
  • Resistance Level
  • IOTR N/A
  • PASG $0.40
  • Average True Range (ATR)
  • IOTR 0.00
  • PASG 0.05
  • MACD
  • IOTR 0.00
  • PASG 0.00
  • Stochastic Oscillator
  • IOTR 0.00
  • PASG 30.00

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: